– USA, CT – Invivyd, Inc. (NASDAQ: IVVD) announced the appointment of Dr. Paul Bolno (M.D.) to its Board of Directors.
Paul Bolno will also join the Compensation Committee.
About Dr. Paul B. Bolno
Dr. Paul Bolno is the President and CEO of Wave Life Sciences, a clinical-stage biotechnology company, and has served in those roles since 2013. He brings diverse experience utilizing technological platforms to create new products and medications. In addition to his role at Wave Life Sciences, he serves on the Board of Directors of ExpressionEdits and is the Chairman of the Scientific Advisory Group for the Nucleic Acid Therapy Accelerator.
About Invivyd
Invivyd, Inc. is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry, designed to assess, monitor, develop, and adapt to create best-in-class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates.
For more information: https://www.invivyd.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.